The Gastrointestinal and Other Cancers Research conducts and supports prevention and early detection research on colorectal, esophageal, liver, pancreatic, and hematolymphoid cancers, as well as new approaches to clinical prevention studies including cancer immunoprevention.

Read more About the Gastrointestinal and Other Cancers Research Group.

Staff

Funding Opportunities

Active Grants

Clinical Trials

Publications

Barrett's Esophagus Translational Research Network (BETRNet)

Multi-disciplinary Research Centers collaborate to enhance understanding of Barrett's esophagus and prevent esophageal adenocarcinoma.

Read more about Barrett's Esophagus Translational Research Network (BETRNet)

Cancer Prevention Clinical Trials Network (CP-CTNet)

Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.

More about the Cancer Prevention Clinical Trials Network (CP-CTNet)

Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

Major medical research centers conduct systematic early clinical development of promising preventive agents.

More about the Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

Think Tank on Aspirin and Non-Steroidal Anti-inflammatory Drugs (NSAIDs) in Cancer Prevention

Date(s) and Time(s): 9/30/2021 9:00 a.m. - 1:30 p.m. ET; 10/1/2021: 9:00 a.m. - 1:00 p.m. ET, View the DRAFT Agenda for this meeting. WebEx information will be provided soon; please check back at a later date. No registration is required to attend.

Pancreatic Cysts Are Monitored in New Trial Aimed at Reducing Cancer Risk Through Targeted Screening

In a new NCI-sponsored study now recruiting participants, investigators will evaluate two different screening strategies for non-cancerous pancreatic cysts to determine which works best at detecting early malignancy.